Company Overview of Ancora Pharmaceuticals, Inc.
Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.
200 Boston Avenue
Medford, MA 02155
Founded in 2001
Key Executives for Ancora Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Copharma, Inc.||United States|
|Crescendo Pharmaceuticals Corporation||United States|
|Cu-Tech, LLC||United States|
|XTuit Pharmaceuticals, Inc.||United States|
|ImQuest Pharmaceuticals, Inc||United States|
Recent Private Companies Transactions
November 1, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | InformaticaPosted: Feb 20
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
Sponsored Financial Commentaries
To contact Ancora Pharmaceuticals, Inc., please visit www.ancorapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.